Similar articles

• An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia.

  Bailey FA, Lilly M, Bertoli LF, Ball GV. Bailey FA, et al. Arthritis Rheum. 1989 Jul;32(7):901-5. Arthritis Rheum. 1989. PMID: 2751721
• Serum inhibitors of hematopoiesis in a patient with aplastic anemia and systemic lupus erythematosus. Recovery after exchange plasmapheresis.

  Fitchen JJ, Cline MJ, Saxon A, Golde DW. Fitchen JJ, et al. Am J Med. 1979 Mar;66(3):537-42. doi: 10.1016/0002-9343(79)91097-0. Am J Med. 1979. PMID: 433958 No abstract available.
• Serum inhibitor in systemic lupus erythematosus associated with aplastic anemia.

  Brooks BJ Jr, Broxmeyer HE, Bryan CF, Leech SH. Brooks BJ Jr, et al. Arch Intern Med. 1984 Jul;144(7):1474-7. Arch Intern Med. 1984. PMID: 6732407
• [Immunological mechanisms in aplastic anemia. II. Clinical data suggesting the role of immunologic disorders in the etiology of aplastic anemia: studies in vitro].

  Rupniewska ZM, Dmoszyńska-Giannopoulos A. Rupniewska ZM, et al. Przegl Lek. 1982;39(10):667-74. Przegl Lek. 1982. PMID: 6218514 Review. Polish. No abstract available.
• [Recent development of hematological study by bone marrow cell culture].

  Niho Y. Niho Y. Fukuoka Igaku Zasshi. 1985 Jan;76(1):1-5. Fukuoka Igaku Zasshi. 1985. PMID: 3922861 Review. Japanese. No abstract available.